A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells

R J Noelle, M Roy, D M Shepherd, I Stamenkovic, J A Ledbetter, A Aruffo, R J Noelle, M Roy, D M Shepherd, I Stamenkovic, J A Ledbetter, A Aruffo

Abstract

CD40 is a B-cell surface molecule that has been shown to induce B-cell growth upon ligation with monoclonal antibodies. This report shows that triggering via CD40 is essential for the activation of resting B cells by helper T cells (Th). A soluble fusion protein of CD40 and human immunoglobulin, CD40-Ig, inhibited the induction of B-cell cycle entry, proliferation, and differentiation by activated Th1 and Th2. The ligand for CD40 was identified as a 39-kDa membrane protein that was selectively expressed on activated Th. A monoclonal antibody specific for the 39-kDa protein inhibited CD40-Ig binding and also inhibited the activation of B cells by Th. These data indicate that the 39-kDa membrane protein expressed on activated Th is a binding protein for CD40 and functions to transduce the signal for Th-dependent B-cell activation.

References

    1. J Exp Med. 1987 Dec 1;166(6):1774-87
    1. Proc Natl Acad Sci U S A. 1987 Mar;84(5):1374-8
    1. J Immunol. 1983 Nov;131(5):2178-83
    1. Hybridoma. 1982;1(3):257-73
    1. Cell. 1990 Jun 29;61(7):1303-13
    1. Science. 1991 Jan 4;251(4989):70-2
    1. J Exp Med. 1991 Mar 1;173(3):705-10
    1. J Immunol. 1991 Mar 15;146(6):1836-42
    1. Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6403-7
    1. Annu Rev Immunol. 1991;9:97-127
    1. J Immunol. 1989 Apr 15;142(8):2736-42
    1. J Immunol. 1989 Sep 15;143(6):1745-54
    1. Eur J Immunol. 1989 Sep;19(9):1551-7
    1. Proc Natl Acad Sci U S A. 1988 Jan;85(2):564-8
    1. Immunol Rev. 1982;68:135-69
    1. J Exp Med. 1982 May 1;155(5):1523-36
    1. J Immunol. 1990 Dec 15;145(12):3956-62
    1. J Exp Med. 1990 Dec 1;172(6):1861-4
    1. J Immunol. 1991 Feb 15;146(4):1118-24
    1. J Immunol. 1991 Mar 15;146(6):1722-9
    1. Scand J Immunol. 1991 Feb;33(2):211-8
    1. J Immunol. 1991 Jul 1;147(1):8-13
    1. J Biol Chem. 1991 Sep 15;266(26):17478-85
    1. J Immunol. 1990 Oct 1;145(7):2025-34
    1. Immunol Rev. 1987 Oct;99:193-239
    1. EMBO J. 1989 May;8(5):1403-10
    1. J Immunol. 1989 Sep 15;143(6):1807-14
    1. J Immunol. 1986 Sep 1;137(5):1718-23

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner